C6orf134 activators constitute a specialized category of chemical compounds known for their ability to modulate the activity of the C6orf134 gene, a relatively less characterized gene with emerging roles in cellular processes. The C6orf134 gene encodes a protein whose functions and mechanisms are actively being studied in the field of molecular biology. These activators are meticulously designed to interact with the regulatory elements of the C6orf134 gene, potentially enhancing its expression and influencing its downstream effects on cellular processes. At the molecular level, the mechanisms through which C6orf134 activators exert their effects can vary, and they may involve interactions with specific DNA regions, transcription factors, or epigenetic modifications that regulate gene expression.
Research on C6orf134 activators is crucial for expanding our understanding of the molecular mechanisms underlying gene regulation and their implications in cellular physiology. Scientists in this field primarily focus on elucidating the precise molecular mechanisms by which these compounds impact C6orf134 gene expression and, subsequently, the cellular pathways influenced by the gene's products. By studying C6orf134 activators, researchers aim to uncover the roles this gene plays in various biological contexts, ultimately contributing to our broader knowledge of gene regulation and the diverse functions of less-characterized genes in cellular biology. These activators serve as essential tools for scientific investigations into the complex web of gene regulation and its implications for cellular processes, furthering our comprehension of the intricacies of molecular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Donepezil | 120014-06-4 | sc-279006 | 10 mg | $74.00 | 3 | |
Acetylcholinesterase inhibitor, increasing acetylcholine levels; might indirectly stimulate C6orf134 expression in response to cholinergic activity. | ||||||
Galanthamine | 357-70-0 | sc-218556 | 10 mg | $320.00 | ||
Allosteric potentiator of nicotinic acetylcholine receptors and acetylcholinesterase inhibitor; could influence C6orf134 expression. | ||||||
PNU 120596 | 501925-31-1 | sc-203200 sc-203200A | 1 mg 5 mg | $32.00 $84.00 | 1 | |
Positive allosteric modulator of α7 nicotinic acetylcholine receptors; could indirectly influence C6orf134 expression. | ||||||
NS 1738 | 501684-93-1 | sc-204136 sc-204136A | 10 mg 50 mg | $149.00 $620.00 | 1 | |
Positive allosteric modulator of α7 nicotinic acetylcholine receptors; potential indirect effects on C6orf134 expression. | ||||||
Cytisine | 485-35-8 | sc-203015 sc-203015A | 5 mg 25 mg | $56.00 $190.00 | ||
Partial agonist of nicotinic acetylcholine receptors; potential influence on C6orf134 expression. | ||||||
Dithioerythritol | 6892-68-8 | sc-202585 sc-202585A | 1 g 5 g | $64.00 $204.00 | ||
Antagonist of nicotinic acetylcholine receptors; might influence C6orf134 expression in response to receptor blockade. | ||||||
Methyllycaconitine citrate | 112825-05-5 | sc-253043 sc-253043A | 5 mg 25 mg | $119.00 $406.00 | 2 | |
α7 nicotinic acetylcholine receptor antagonist; potential indirect effects on C6orf134 expression. | ||||||
α-Bungarotoxin | 11032-79-4 | sc-202897 | 1 mg | $351.00 | 5 | |
Toxin that binds irreversibly to nicotinic acetylcholine receptors; could influence C6orf134 expression in response to receptor blockade. | ||||||